Logo Centene Corporation

Centene Corporation (CNC) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Centene Corporation · Health Care · ref. ETF XLV · 62 calls · price $65.33
🏆JPI 2026 portfoliosSee tracking →
What the company does: Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.

📈 Centene Corporation (CNC) stock price

$65.33+130.2% over range
Aug 28, 25low $28.38 · high $68.72Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
47% recommend buying · 17 analysts
📊 JPI status : Centene Corporation is no longer in our current JPI rankings, but appeared in the past (2017) — its upside may be behind it. See the stocks picked in 2017 →

🎯 CNC price target & analyst consensusprice $65.33

The price target · all analysts combined (17 targets)
Highest target · 3 firms of 17$80+22.5%
Median target · of 17 targets$69+5.6%
Lowest target · 1 firm of 17$39-40.3%
Current price$65.33
Where these 17 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 1165% $66 ↔ $80
Below 635% $39 ↔ $65
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Morgan Stanley69% of its targets hit on this sector (825 calls tested). It aims for $57 (-13 %), call made on June 5, 2026, maturing on June 5, 2027 (84 d ago).

The 11 reliable analysts $69+5.6 %
The 6 other firms $66+1.0 %
How to read it: the 11 reliable firms are not filtered by optimism — 8 aim above the price, 3 below, hence their $69 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 17 ratings (last 6 months)
Strong Buy00%
Buy847%
Hold953%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Centene Corporation? The JPI assistant answers using our backtest data.

📈 Centene Corporation fundamentals: valuation, margins & growth › open the full page

P/E Net margin -2.8 %Revenue growth +4.6 %Not (yet) profitable

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 1 %
2023
Rev +7%Profit +125%
2024
Rev +6%Profit +22%
2025
Rev +19%Profit −302%

🔎 Detailed analyses

🏛️ Which US Congress members hold Centene Corporation (CNC)?

6 Congress members have disclosed CNC buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Susie Lee · 43%Kathy Manning · 43%Gilbert Cisneros · 48%Earl Blumenauer · 38%Daniel Goldman · 25%David McKinley · 38%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on CNC

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Monness, Crespi, Hardt 100% +38.4% 3
SVB Leerink 100% +22.2% 3
BMO Capital  100% +17.4% 6
Stephens & Co.  100% +11.5% 4
FBR Capital 75% +60.2% 4
Credit Suisse 67% +29.0% 12
Cowen & Co. 67% +3.2% 3
B of A Securities  67% -4.3% 9
Morgan Stanley  65% +12.5% 26
Jefferies  64% +8.8% 14
See the other 15 firms
TD Cowen  0% -62.3% 2
Wells Fargo  25% -18.7% 16
Citigroup  27% -23.2% 11
UBS  33% +10.2% 3
Cantor Fitzgerald  37% -3.6% 19
Leerink Swann 40% +28.9% 5
Barclays  43% -4.9% 21
Goldman Sachs  50% +2.2% 2
SunTrust Robinson Humphrey 50% +3.3% 2
Bernstein  50% +18.6% 2
Susquehanna  50% +35.0% 2
Oppenheimer  53% +19.8% 19
Deutsche Bank  56% +14.7% 9
Truist Securities  56% +17.1% 9
JP Morgan  60% +27.7% 5

📊 What $1,000 invested in Centene Corporation would be worth › open the full page

In short — $1,000 invested in Centene Corporation 10 years ago would be worth $1,951 today, i.e. +7%/yr on average. Best year: 2017 (+79%), worst: 2025 (-32%). Price performance, excluding dividends.

If I'd invested $1,000 in Centene Corporation

InvestmentWorth todayGain
1 years ago$1,060+6%
3 years ago$783-22%
5 years ago$1,069+7%
→ See Centene Corporation's full return history + gain calculator

Return by year (Centene Corporation)

YearReturn$1,000 invested at year start
2026 (YTD)+56%$1,560 (+56%)
2025-32%$1,060 (+6%)
2024-18%$865 (-14%)
→ See Centene Corporation's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Centene Corporation

Loading news…

📋 All analyst calls on CNC

Argus Research 
Aug 11, 26
▲ Buy · 🎯$80
Price at call : $64.88 — upside +23%
Today : $65.33 — upside +22%
🎯 on CNC : no call matured yet · 📊 on Health : 55.7% · +2.6% (158 calls)
in progress (365j)
matures : Aug 11, 27
JP Morgan 
Aug 4, 26
■ Neutral neutral · not a buy · 🎯$67
Price at call : $66.99 — gap to target +0%
Today : $65.33 — gap to target +3%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Aug 4, 27
Bernstein 
Aug 3, 26
▲ Outperform · 🎯$79
Price at call : $64.07 — upside +23%
Today : $65.33 — upside +21%
🎯 on CNC : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Aug 3, 27
Barclays 
Jul 29, 26
▲ Overweight · 🎯$80
Price at call : $61.82 — upside +29%
Today : $65.33 — upside +22%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jul 29, 27
Baird 
Jul 29, 26
■ Neutral neutral · not a buy · 🎯$66
Price at call : $61.82 — gap to target +7%
Today : $65.33 — gap to target +1%
🎯 on CNC : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 29, 27
TD Cowen 
Jul 14, 26
■ Hold neutral · not a buy · 🎯$65
Price at call : $66.61 — gap to target -2%
Today : $65.33 — gap to target -1%
🎯 on CNC : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 14, 27
▲ Buy · 🎯$78
Price at call : $68.72 — upside +14%
Today : $65.33 — upside +19%
🎯 on CNC : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 14, 27
Wells Fargo 
Jul 13, 26
■ Equal-Weight neutral · not a buy · 🎯$69
Price at call : $68.72 — gap to target +0%
Today : $65.33 — gap to target +6%
🎯 on CNC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 13, 27
See the other 54 calls, newest to oldest
RBC Capital 
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$71
Price at call : $67.35 — gap to target +5%
Today : $65.33 — gap to target +9%
🎯 on CNC : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 9, 27
▲ Overweight · 🎯$75
Price at call : $66.12 — upside +13%
Today : $65.33 — upside +15%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Jul 7, 27
RBC Capital 
Jun 23, 26
■ Sector Perform neutral · not a buy · 🎯$70
Price at call : $62.97 — gap to target +11%
Today : $65.33 — gap to target +7%
🎯 on CNC : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jun 23, 27
Mizuho 
Jun 8, 26
■ Neutral neutral · not a buy · 🎯$63
Price at call : $66.21 — gap to target -5%
Today : $65.33 — gap to target -4%
🎯 on CNC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jun 8, 27
JP Morgan 
Jun 8, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $66.21 — gap to target -9%
Today : $65.33 — gap to target -8%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jun 8, 27
▲ Buy · 🎯$74
Price at call : $62.33 — upside +19%
Today : $65.33 — upside +13%
🎯 on CNC : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jun 4, 27
■ Equal-Weight neutral · not a buy · 🎯$57
Price at call : $62.33 — gap to target -9%
Today : $65.33 — gap to target -13%
🎯 on CNC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jun 4, 27
▲ Buy · 🎯$71
Price at call : $59.99 — upside +18%
Today : $65.33 — upside +9%
🎯 on CNC : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jun 1, 27
Barclays 
May 26, 26
▲ Overweight · 🎯$75
Price at call : $58.82 — upside +28%
Today : $65.33 — upside +15%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 26, 27
UBS 
May 22, 26
■ Neutral neutral · not a buy · 🎯$61
Price at call : $57.21 — gap to target +7%
Today : $65.33 — gap to target -7%
🎯 on CNC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 22, 27
▲ Buy · 🎯$72
Price at call : $57.77 — upside +25%
Today : $65.33 — upside +10%
🎯 on CNC : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : May 21, 27
Mizuho 
May 20, 26
■ Neutral neutral · not a buy · 🎯$58
Price at call : $58.28 — gap to target -0%
Today : $65.33 — gap to target -11%
🎯 on CNC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : May 20, 27
Deutsche Bank 
May 20, 26
▲ Buy · 🎯$80
Price at call : $58.28 — upside +37%
Today : $65.33 — upside +22%
🎯 on CNC : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : May 20, 27
TD Cowen 
May 4, 26
■ Hold neutral · not a buy · 🎯$47
Price at call : $52.98 — gap to target -11%
Today : $65.33 — gap to target -28%
🎯 on CNC : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : May 4, 27
Wells Fargo 
May 1, 26
■ Equal-Weight neutral · not a buy · 🎯$56
Price at call : $53.56 — gap to target +5%
Today : $65.33 — gap to target -14%
🎯 on CNC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 1, 27
UBS 
Apr 29, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $53.69 — gap to target +2%
Today : $65.33 — gap to target -16%
🎯 on CNC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Apr 29, 27
Oppenheimer 
Apr 29, 26
▲ Outperform · 🎯$58
Price at call : $53.69 — upside +8%
Today : $65.33 — upside -11%
🎯 on CNC : no call matured yet · 📊 on Health : 44.1% · +0.6% (220 calls)
in progress (365j)
matures : Apr 29, 27
▲ Overweight · 🎯$60
Price at call : $53.69 — upside +12%
Today : $65.33 — upside -8%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Apr 29, 27
Barclays 
Apr 29, 26
▲ Overweight · 🎯$63
Price at call : $53.69 — upside +17%
Today : $65.33 — upside -4%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 29, 27
▲ Buy · 🎯$58
Price at call : $53.98 — upside +7%
Today : $65.33 — upside -11%
🎯 on CNC : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 29, 27
▲ Buy · 🎯$60
Price at call : $53.98 — upside +11%
Today : $65.33 — upside -8%
🎯 on CNC : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Apr 29, 27
Jefferies 
Apr 20, 26
■ Hold neutral · not a buy · 🎯$39
Price at call : $39.14 — gap to target -0%
Today : $65.33 — gap to target -40%
🎯 on CNC : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Apr 20, 27
JP Morgan 
Mar 19, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $34.4 — gap to target +19%
Today : $65.33 — gap to target -37%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Mar 19, 27
Mizuho 
Mar 11, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $35.86 — gap to target +14%
Today : $65.33 — gap to target -37%
🎯 on CNC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Mar 11, 27
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $43.27 — gap to target +4%
Today : $65.33 — gap to target -31%
🎯 on CNC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Mar 4, 27
Wells Fargo 
Feb 18, 26
■ Equal-Weight neutral · not a buy · 🎯$44
Price at call : $43.07 — gap to target +2%
Today : $65.33 — gap to target -33%
🎯 on CNC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 18, 27
■ Neutral neutral · not a buy · 🎯$41
Price at call : $38.04 — gap to target +8%
Today : $65.33 — gap to target -37%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Feb 9, 27
Wells Fargo 
Jan 7, 26
■ Equal-Weight neutral · not a buy · 🎯$43
Price at call : $46.92 — gap to target -8%
Today : $65.33 — gap to target -34%
🎯 on CNC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jan 7, 27
Barclays 
Jan 5, 26
▲ Overweight · 🎯$54
Price at call : $44.68 — upside +21%
Today : $65.33 — upside -17%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 5, 27
Bernstein 
Nov 21, 25
▲ Outperform · 🎯$45
Price at call : $38.17 — upside +18%
Today : $65.33 — upside -31%
🎯 on CNC : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Nov 21, 26
Wells Fargo 
Nov 12, 25
■ Equal-Weight neutral · not a buy · 🎯$35
Price at call : $36.09 — gap to target -3%
Today : $65.33 — gap to target -46%
🎯 on CNC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 12, 26
JP Morgan 
Nov 4, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $36.84 — gap to target +3%
Today : $65.33 — gap to target -42%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 4, 26
Barclays 
Nov 4, 25
■ Equal-Weight neutral · not a buy · 🎯$44
Price at call : $36.11 — gap to target +22%
Today : $65.33 — gap to target -33%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Nov 4, 26
TD Cowen 
Oct 31, 25
■ Hold neutral · not a buy · 🎯$34
Price at call : $34.5 — gap to target -1%
Today : $65.33 — gap to target -48%
🎯 on CNC : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Oct 31, 26
Goldman Sachs 
Oct 31, 25
▼ Sell · 🎯$38
Price at call : $34.5 — upside +10%
Today : $65.33 — upside -42%
🎯 on CNC : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 31, 26
UBS 
Oct 30, 25
■ Neutral neutral · not a buy · 🎯$42
Price at call : $35.37 — gap to target +19%
Today : $65.33 — gap to target -36%
🎯 on CNC : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 30, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $35.37 — gap to target +16%
Today : $65.33 — gap to target -37%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Oct 30, 26
▲ Buy · 🎯$45
Price at call : $35.02 — upside +28%
Today : $65.33 — upside -31%
🎯 on CNC : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Oct 30, 26
Morgan Stanley 
Oct 14, 25
■ Equal-Weight neutral · not a buy · 🎯$38
Price at call : $35.79 — gap to target +6%
Today : $65.33 — gap to target -42%
🎯 on CNC : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Oct 14, 26
Goldman Sachs 
Oct 14, 25
▼ Sell · 🎯$33
Price at call : $36.44 — upside -9%
Today : $65.33 — upside -49%
🎯 on CNC : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 14, 26
Mizuho 
Oct 9, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $37.83 — gap to target +6%
Today : $65.33 — gap to target -39%
🎯 on CNC : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Oct 9, 26
Wells Fargo 
Oct 7, 25
■ Equal-Weight neutral · not a buy · 🎯$41
Price at call : $38.45 — gap to target +7%
Today : $65.33 — gap to target -37%
🎯 on CNC : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Oct 7, 26
▲ Overweight · 🎯$65
Price at call : $33.78 — upside +92%
Today : $65.33 — upside -1%
Expected +92% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
+100.9%
stock +101% · XLV +21%
matured Jul 2, 26
▲ Overweight · 🎯$90
Price at call : $58 — upside +55%
Today : $65.33 — upside +38%
Expected +55% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-29.6%
stock -30% · XLV +9%
matured Dec 11, 25
▲ Overweight · 🎯$90
Price at call : $72.62 — upside +24%
Today : $65.33 — upside +38%
Expected +24% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-49.3%
stock -49% · XLV -6%
matured Oct 1, 25
▲ Overweight · 🎯$90
Price at call : $75.35 — upside +19%
Today : $65.33 — upside +38%
Expected +19% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-56.6%
stock -57% · XLV -12%
matured Sep 20, 25
▲ Overweight · 🎯$90
Price at call : $73.47 — upside +22%
Today : $65.33 — upside +38%
Expected +22% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-53.6%
stock -54% · XLV -10%
matured Sep 10, 25
▲ Overweight · 🎯$90
Price at call : $78.16 — upside +15%
Today : $65.33 — upside +38%
Expected +15% · Actual -62% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-62.4%
stock -62% · XLV -11%
matured Aug 19, 25
▲ Overweight · 🎯$90
Price at call : $66.12 — upside +36%
Today : $65.33 — upside +38%
Expected +36% · Actual -60% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-59.5%
stock -60% · XLV -9%
matured Jul 23, 25
▲ Overweight · 🎯$90
Price at call : $68.98 — upside +30%
Today : $65.33 — upside +38%
Expected +30% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-20.0%
stock -20% · XLV -7%
matured Jun 12, 25
▲ Overweight · 🎯$90
Price at call : $72.78 — upside +24%
Today : $65.33 — upside +38%
Expected +24% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-15.7%
stock -16% · XLV -6%
matured Apr 4, 25
▲ Overweight · 🎯$90
Price at call : $74.22 — upside +21%
Today : $65.33 — upside +38%
Expected +21% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-20.3%
stock -20% · XLV +4%
matured Dec 14, 24
▲ Overweight · 🎯$82
Price at call : $74.21 — upside +10%
Today : $65.33 — upside +26%
Expected +10% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-18.7%
stock -19% · XLV +10%
matured Nov 20, 24
▲ Overweight · 🎯$82
Price at call : $67.81 — upside +21%
Today : $65.33 — upside +26%
Expected +21% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
+12.9%
stock +13% · XLV +19%
matured Sep 13, 24

Frequently asked questions

Should I buy Centene Corporation stock?

This isn't buy advice. For Centene Corporation, the analyst consensus is "Hold", with an average price target of $69.00 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Centene Corporation). We show the numbers — you decide.

Is it too late to buy Centene Corporation? How high can it go?

The most bullish analyst target on Centene Corporation is $80.00 (+22% above today's price); the average is $69.00. That's the upside they see. Check how reliable those analysts have actually been on Centene Corporation on our site before trusting it.

Is Centene Corporation still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 25 analysts have a real record on Centene Corporation, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Centene Corporation? The case for and against

The arguments for and against, one by one, from the numbers: why invest in CNC (and why hesitate).

What has Centene Corporation's past performance been?

Historical returns and a "how much if I had invested" calculator: CNC performance & returns.

What is the best month to buy CNC?

The 12 months ranked by the stock's past returns: best & worst month to buy CNC.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)